Other substances

Imiglitazar

A peroxisome proliferator-activated receptor agonist.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

Imiglitazar on PubChem

 

Structure image - Imiglitazar

CC1=C(N=C(O1)C2=CC=CC=C2)COC3=CC=C(C=C3)CO/N=C(\CCC(=O)O)/C4=CC=CC=C4

Supporting references

Link Tested on Impact factor Notes Publication date
Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19
3CLpro Small molecule In silico 		in silico 2.80

Predicted to bind SARS-CoV-2 3C-like protease.

 Feb/23/2021
Export (.csv)